AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marchand, S.
Right arrow Articles by Couet, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marchand, S.
Right arrow Articles by Couet, W.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2006, p. 371-373, Vol. 50, No. 1
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.1.371-373.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Norfloxacin Blood-Brain Barrier Transport in Rats Is Not Affected by Probenecid Coadministration

Sandrine Marchand,1,2 Anna Forsell,1 Marylore Chenel,1,3 Emmanuelle Comets,4 Isabelle Lamarche,1 and William Couet1,2*

EA 3809, Faculté de Médecine et de Pharmacie, BP 199, 34 rue du Jardin des Plantes, 86005 Poitiers Cedex, France,1 Laboratoire de Pharmacocine'tique, PBS, CHU La Mile'trie, 40 avenue du Recteur Pineau, 86022 Poitiers Cedex, France,2 University of Manchester, Manchester, United Kingdom,3 INSERM U738, Department of Epidemiology, Biostatistics and Clinical research, AP-HP, Bichat University Hospital, Paris, France4

Received 9 March 2005/ Returned for modification 22 May 2005/ Accepted 30 October 2005

The effect of probenecid (PRO) on norfloxacin (NOR) blood-brain barrier transport was investigated with rats by microdialysis. Maximum brain drug concentrations were rapidly attained, and the brain penetration factor was close to 5% in the absence and presence of PRO. In conclusion, PRO has no effect on NOR blood-brain barrier transport.

* Corresponding author. Mailing address: Pôle Biologie Santé, 40 avenue du Recteur Pineau, 86022 Poitiers Cedex, France. Phone: 33-5-49-45-43-79. Fax: 33-5-49-45-43-78. E-mail: william.couet{at}univ-poitiers.fr.

Antimicrobial Agents and Chemotherapy, January 2006, p. 371-373, Vol. 50, No. 1
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.1.371-373.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.